Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis

• Những tác giả chính: Ju Li (Tác giả), Zhongyuan Zhang (Tác giả), Xinhua Wu (Tác giả), Jie Zhou (Tác giả), Deqian Meng (Tác giả), Ping Zhu (Tác giả)
• Định dạng: Sách
• Được phát hành: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Background: Adalimumab, golimumab, infliximab, certolizumab, and etanercept are five anti-tumor necrosis factor (anti-TNF) medicines that have been approved for use in rheumatology. Apart from their well-established therapeutic usefulness, -it is unclear to what extent -they are linked to an increas...